Public Title:A Study on the Registration of The Use of Feilike HeJi in Adults

NCT ID: NCT04714489

Last Updated: 2021-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-16

Study Completion Date

2021-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Feilike HeJi is produced by Guizhou Jianxing Pharmaceutical Co. LTD. For the treatment of phlegm heat caused by lung cough phlegm yellow, bronchial asthma, bronchitis, see the syndrome of proprietary Chinese medicine (approval number: Z20025136) approved by the state and the drug from radix scutellariae, radix peucedani, radix stemonae, red gentian root of deal, phoenix tree, spreading hedyotis herb, red tube 7 flavour, with qingrejiedu, antitussive expectorant effect. In order to fully understand the safety of Feilike HeJi in clinical practice and fulfill the responsibility of production enterprises for patients, the production enterprises initiated this study to further evaluate the safety and understanding of the function characteristics of Feilike HeJi in a wide range of people, so as to guide the clinical rational drug use.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bronchial Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

experimental group

NO.

Intervention Type OTHER

NO.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NO.

NO.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All adult patients (age ≥18 years old) who use Feilike HeJi at the specified monitoring time and in the monitoring center (department) ;
* Must voluntarily participate in this study;
* Must meet ethical requirements.

Exclusion Criteria

* NO
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

China Academy of Chinese Medical Sciences

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zhong Wang

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hongchun Zhang, M.D.

Role: STUDY_DIRECTOR

China-Japan Friendship Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

China-Japan Friendship Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Peking University Third Hospital Yanqing Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

The First Affiliated Hospital Of Guangzhou Medical University

Guangzhou, Guangdong, China

Site Status RECRUITING

The Eighth Affiliated Hospital, Sun Yat-sen University

Shenzhen, Guangdong, China

Site Status NOT_YET_RECRUITING

Southern University of Science and Technology Hospital

Shenzhen, Guangdong, China

Site Status NOT_YET_RECRUITING

Guizhou Provincial People's Hospital

Guiyang, Guizhou, China

Site Status NOT_YET_RECRUITING

The Second People's Hospital of Guiyang

Guiyang, Guizhou, China

Site Status NOT_YET_RECRUITING

Henan Provincial People's Hospital

Zhengzhou, Henan, China

Site Status NOT_YET_RECRUITING

First Affiliated Hospital, Hunan University of Traditional Chinese Medicine

Changsha, Hunan, China

Site Status NOT_YET_RECRUITING

People's Hospital of Ningxiang

Changsha, Hunan, China

Site Status RECRUITING

Xiangtan County People's Hospital

Changsha, Hunan, China

Site Status RECRUITING

Nanjing Central Hospital

Nanjing, Jiangsu, China

Site Status RECRUITING

Yifu Hospital Affiliated to Nanjing Medical University

Nanjing, Jiangsu, China

Site Status NOT_YET_RECRUITING

Nanjing Jiangning Hospital of traditional Chinese Medicine

Nanjing, Jiangsu, China

Site Status NOT_YET_RECRUITING

Guixi People's Hospital, Jiangxi Province

Guixi, Jiangxi, China

Site Status RECRUITING

Jiangxi University of Traditional Chinese Medicine Affiliated Hospital

Nanchang, Jiangxi, China

Site Status NOT_YET_RECRUITING

Wanzai County People's Hospital, Jiangxi Province

Yichun, Jiangxi, China

Site Status RECRUITING

Changchun Second Hospital

Changchun, Jilin, China

Site Status NOT_YET_RECRUITING

People's Hospital of Fuxin Mongolian Autonomous County

Fuxin, Liaoning, China

Site Status RECRUITING

First People's Hospital of Jining City

Jining, Shandong, China

Site Status RECRUITING

People's Hospital of Mengyin County

Linyi, Shandong, China

Site Status NOT_YET_RECRUITING

Hanyin County People's Hospital, Shaanxi Province

Ankang, Shanxi, China

Site Status NOT_YET_RECRUITING

First Affiliated Hospital of Xi'an Medical College

Xian, Shanxi, China

Site Status NOT_YET_RECRUITING

Peking University Binhai Hospital

Tianjin, Tianjin Municipality, China

Site Status NOT_YET_RECRUITING

Tianjin First Central Hospital

Tianjin, Tianjin Municipality, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hongchun Zhang, M.D.

Role: CONTACT

+86 13701226664

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hongchun Zhang, M.D.

Role: primary

+86 13701226664

Yanling Yang, Bachelor

Role: primary

13651362302

Luxi Zhou, Doctor

Role: primary

18926132976

Xiaoke Chen, Master

Role: primary

15013817336

Yumei Wang, Master

Role: primary

13425198757

Kui Zhang, Doctor

Role: primary

13765022378

Xueying Chen, Bachelor

Role: primary

13985045820

Xiao Li, Doctor

Role: primary

13526809196

Fuyuan Fan, Doctor

Role: primary

13607314168

JUfeng Yu, Bachelor

Role: primary

13755151388

Hongyan Zhu, Bachelor

Role: primary

13787327608

Jun Zhao, Bachelor

Role: primary

13912913107

Xiaolin Chen, Master

Role: primary

18805147755

Yanqiu Xu, Master

Role: primary

13851745719

Jieyang Wu, Bachelor

Role: primary

13870168030

Yuanbing Zhang, Master

Role: primary

13970990051

Yang Song, Bachelor

Role: primary

15970536310

Yun Liu, Bachelor

Role: primary

18643191435

Yaguang Shi, Bachelor

Role: primary

13841837189

Jiping Yang, Master

Role: primary

18678769825

Shuwei Zhang, Bachelor

Role: primary

15963975076

Houfang He, Bachelor

Role: primary

18609157810

Shengli Wang

Role: primary

13991806428

Shaoxiang C Huang, Bachelor

Role: primary

13920412271

Aidong Liu, Master

Role: primary

13920412271

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Felike V1.0

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Idiopathic Pulmonary Fibrosis Cohort of TCM
NCT07162870 NOT_YET_RECRUITING
Effectiveness of Chinese Herbal Therapy for Asthma
NCT00712296 TERMINATED PHASE1/PHASE2